On the public citation graph

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

https://doi.org/10.1007/s00259-003-1194-1
0 signed · 608 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneur.1991.00530150046016openalex-snapshot
Detection of Abnormal Memory Decline in Mild Cases of Alzheimer's Disease Using CERAD Neuropsychological Measures
inferredcites →https://doi.org/10.1001/archneur.56.3.303openalex-snapshot
Mild Cognitive Impairment
inferredcites →https://doi.org/10.1001/archneur.58.9.1403openalex-snapshot
Selective Preservation and Degeneration Within the Prefrontal Cortex in Aging and Alzheimer Disease
inferredcites →https://doi.org/10.1002/0470846410.ch42(iii)openalex-snapshot
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
inferredcites →https://doi.org/10.1002/1531-8249(20010201)49:2<202::aid-ana40>3.0.co;2-3openalex-snapshot
Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment
inferredcites →https://doi.org/10.1002/ana.410420114openalex-snapshot
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
inferredcites →https://doi.org/10.1002/gps.930010209openalex-snapshot
The challenge of time: Clock‐drawing and cognitive function in the elderly
inferredcites →https://doi.org/10.1006/nimg.1998.0381openalex-snapshot
Rapid Assessment of Regional Cerebral Metabolic Abnormalities in Single Subjects with Quantitative and Nonquantitative [18F]FDG PET: A Clinical Validation of Statistical Parametric Mapping
inferredcites →https://doi.org/10.1007/978-3-7091-6467-9_21openalex-snapshot
Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia
inferredcites →https://doi.org/10.1007/bf02988628openalex-snapshot
Clinical application of positron emission tomography for diagnosis of dementia
inferredcites →https://doi.org/10.1007/s002210050445openalex-snapshot
Dependence of short-latency ocular following and associated activity in the medial superior temporal area (MST) on ocular vergence
inferredcites →https://doi.org/10.1016/0022-3956(82)90033-4openalex-snapshot
Development and validation of a geriatric depression screening scale: A preliminary report
inferredcites →https://doi.org/10.1016/0022-3956(95)00032-1openalex-snapshot
Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: A SPECT blood flow study
inferredcites →https://doi.org/10.1016/s0140-6736(06)68542-5openalex-snapshot
Mild cognitive impairment
inferredcites →https://doi.org/10.1016/s0197-4580(00)82810-9openalex-snapshot
The cerad neuropsychological assessment battery (Cerad-NAB)—A minimal data set as a common tool for German-speaking Europe
inferredcites →https://doi.org/10.1017/s1041610297004717openalex-snapshot
Aging, Memory, and Mild Cognitive Impairment
inferredcites →https://doi.org/10.1034/j.1600-0404.107.s179.10.xopenalex-snapshot
A critical discussion of the role of neuroimaging in mild cognitive impairment*
inferredcites →https://doi.org/10.1037/0894-4105.20.6.625openalex-snapshot
Overdependence on degraded gist memory in Alzheimer's disease.
inferredcites →https://doi.org/10.1073/pnas.090106797openalex-snapshot
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
inferredcites →https://doi.org/10.1093/brain/121.1.135openalex-snapshot
Cognitive process in preclinical phase of dementia
inferredcites →https://doi.org/10.1097/00001756-200103260-00045openalex-snapshot
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment
inferredcites →https://doi.org/10.1159/000353457openalex-snapshot
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
inferredcites →https://doi.org/10.1212/wnl.34.7.939openalex-snapshot
Clinical diagnosis of Alzheimer's disease
inferredcites →https://doi.org/10.1212/wnl.39.9.1159openalex-snapshot
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
inferredcites →https://doi.org/10.1212/wnl.43.12.2457openalex-snapshot
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
inferredcites →https://doi.org/10.1212/wnl.43.2.250openalex-snapshot
Vascular dementia
inferredcites →https://doi.org/10.1212/wnl.44.4.609openalex-snapshot
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery
inferredcites →https://doi.org/10.1212/wnl.51.6.1546openalex-snapshot
Frontotemporal lobar degeneration
inferredcites →https://doi.org/10.2967/jnumed.120.252510aopenalex-snapshot
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4095752openalex-extracted
APOE ε4 and Alzheimer's Disease Diagnosis Associated Differences in L-Carnitine, GBB, TMAO and Acylcarnitines in Blood and Brain
inferred← citeshttps://doi.org/10.1001/archneurol.2010.34openalex-snapshot
Comparing Fludeoxyglucose F18–PET Assessment of Regional Cerebral Glucose Metabolism and [11C]Dihydrotetrabenazine–PET in Evaluation of Early Dementia and Mild Cognitive Impairment
inferred← citeshttps://doi.org/10.1001/archneurol.2011.123openalex-snapshot
Longitudinal Change of Biomarkers in Cognitive Decline
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2019.7978openalex-snapshot
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
inferred← citeshttps://doi.org/10.1001/jamaneurol.2013.1425openalex-snapshot
Growth Hormone–Releasing Hormone Effects on Brain γ-Aminobutyric Acid Levels in Mild Cognitive Impairment and Healthy Aging
inferred← citeshttps://doi.org/10.1002/047009057x.ch94openalex-snapshot
Mild Cognitive Impairment
inferred← citeshttps://doi.org/10.1002/14651858.cd010632.pub2openalex-snapshot
18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
inferred← citeshttps://doi.org/10.1002/9780470571224.pse237openalex-snapshot
Biomarkers in Clinical Drug Development: Parallel Analysis of Alzheimer Disease and Multiple Sclerosis
inferred← citeshttps://doi.org/10.1002/9781118730676.ch7openalex-snapshot
Imaging of the Geriatric Brain
inferred← citeshttps://doi.org/10.1002/9781119968900.ch4openalex-snapshot
Dementia
inferred← citeshttps://doi.org/10.1002/9783527831326.ch10openalex-snapshot
Carbohydrates and Carbohydrate‐Based Therapeutics in Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/alz.12757openalex-snapshot
Biomarkers for dementia in Latin American countries: Gaps and opportunities
inferred← citeshttps://doi.org/10.1002/ana.23650openalex-snapshot
Amyloid deposition, hypometabolism, and longitudinal cognitive decline
inferred← citeshttps://doi.org/10.1002/ana.27226openalex-snapshot
Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome
inferred← citeshttps://doi.org/10.1002/cbic.201200478openalex-snapshot
O‐GlcNAc Modification Prevents Peptide‐Dependent Acceleration of α‐Synuclein Aggregation
inferred← citeshttps://doi.org/10.1002/gps.1060openalex-snapshot
Current awareness in geriatric psychiatry
inferred← citeshttps://doi.org/10.1002/gps.2216openalex-snapshot
Voxel based morphometry features and follow‐up of amnestic patients at high risk for Alzheimer's disease conversion
inferred← citeshttps://doi.org/10.1002/gps.2738openalex-snapshot
Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease
inferred← citeshttps://doi.org/10.1002/gps.4102openalex-snapshot
Concordance between 99mTc‐ECD SPECT and 18F‐FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA‐AA criteria
inferred← citeshttps://doi.org/10.1002/gps.4161openalex-snapshot
Apathy as a feature of prodromal Alzheimer's disease: an FDG‐PET ADNI study
inferred← citeshttps://doi.org/10.1002/hbm.22642openalex-snapshot
Manifold regularized multitask feature learning for multimodality disease classification
inferred← citeshttps://doi.org/10.1002/hbm.24207openalex-snapshot
Identification of Alzheimer's disease and mild cognitive impairment using multimodal sparse hierarchical extreme learning machine
inferred← citeshttps://doi.org/10.1002/ima.20218openalex-snapshot
Arterial spin labeling at ultra‐high field: All that glitters is not gold
inferred← citeshttps://doi.org/10.1002/ima.20221openalex-snapshot
Challenges for molecular neuroimaging with MRI
inferred← citeshttps://doi.org/10.1002/jnr.24064openalex-snapshot
The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction
inferred← citeshttps://doi.org/10.1002/jnr.24739openalex-snapshot
Hippocampal subregional volume changes in elders classified using positron emission tomography‐based Alzheimer's biomarkers of β‐amyloid deposition and neurodegeneration
inferred← citeshttps://doi.org/10.1002/mds.28373openalex-snapshot
FDG‐PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome
inferred← citeshttps://doi.org/10.1002/nbm.1712openalex-snapshot
Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by 1H MRS in vitro
inferred← citeshttps://doi.org/10.1002/prca.201000070openalex-snapshot
Lectin‐affinity chromatography brain glycoproteomics and Alzheimer disease: Insights into protein alterations consistent with the pathology and progression of this dementing disorder
inferred← citeshttps://doi.org/10.1007/0-387-31216-1_8openalex-snapshot
Neuroimaging in Alzheimer Disease
inferred← citeshttps://doi.org/10.1007/978-0-387-38335-4_13openalex-snapshot
PET in Neurology
inferred← citeshttps://doi.org/10.1007/978-0-387-72076-0_18openalex-snapshot
Alzheimer’s Disease Neuroimaging Initiative
inferred← citeshttps://doi.org/10.1007/978-0-387-76420-7_3openalex-snapshot
FDG PET in the Evaluation of Mild Cognitive Impairment and Early Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4419-0345-7_42openalex-snapshot
Simultaneous PET and MR Imaging of the Human Brain
inferred← citeshttps://doi.org/10.1007/978-1-4419-0802-5_13openalex-snapshot
Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-1-4419-5955-3_14openalex-snapshot
Translational Research in Alzheimer’s Disease for Development of Antibody-Based Therapeutics
inferred← citeshttps://doi.org/10.1007/978-1-4419-6373-4_19openalex-snapshot
Neuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias
inferred← citeshttps://doi.org/10.1007/978-1-4419-7104-3_18openalex-snapshot
Oxidative Stress and Alzheimer Disease: Mechanisms and Therapeutic Opportunities
inferred← citeshttps://doi.org/10.1007/978-1-4419-7777-9_10openalex-snapshot
10 Neuroimaging in Alzheimer Disease
inferred← citeshttps://doi.org/10.1007/978-1-4614-1788-0_10openalex-snapshot
Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)
inferred← citeshttps://doi.org/10.1007/978-1-4614-3320-0_17openalex-snapshot
Dementia and Alzheimer Disease: Evidence-Based Neuroimaging
inferred← citeshttps://doi.org/10.1007/978-1-4939-7704-8_14openalex-snapshot
The Use of 18F-FDG PET in the Diagnostic Workup of Alzheimer’s Dementia
inferred← citeshttps://doi.org/10.1007/978-3-030-53168-3_10openalex-snapshot
Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
inferred← citeshttps://doi.org/10.1007/978-3-030-66773-3_1openalex-snapshot
Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-030-82367-2_37openalex-snapshot
Vascular Cognitive Impairment
inferred← citeshttps://doi.org/10.1007/978-3-031-80849-4_14openalex-snapshot
Biomarkers in Clinical Trials of Alzheimer Disease: An Overview
inferred← citeshttps://doi.org/10.1007/978-3-319-02267-3_32openalex-snapshot
Sparse Multimodal Manifold-Regularized Transfer Learning for MCI Conversion Prediction
inferred← citeshttps://doi.org/10.1007/978-3-319-30081-8_26openalex-snapshot
Nuclear Imaging of Dementia
inferred← citeshttps://doi.org/10.1007/978-3-319-40070-9_20openalex-snapshot
PET in Neurological and Psychiatric Disorders: Technologic Advances and Clinical Applications
inferred← citeshttps://doi.org/10.1007/978-3-319-68843-5_1openalex-snapshot
Multi-modality Feature Learning in Diagnoses of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-540-28026-2_3openalex-snapshot
Brain
inferred← citeshttps://doi.org/10.1007/978-3-642-17805-4_16openalex-snapshot
Neurologie
inferred← citeshttps://doi.org/10.1007/978-3-642-54307-4_10openalex-snapshot
Aβ Imaging in Aging, Alzheimer’s Disease and Other Neurodegenerative Conditions
inferred← citeshttps://doi.org/10.1007/978-3-642-54307-4_9openalex-snapshot
Dementia Due to Neurodegenerative Disease: Molecular Imaging Findings
inferred← citeshttps://doi.org/10.1007/978-3-662-48842-3_24openalex-snapshot
Neurologische und dementielle Erkrankungen
inferred← citeshttps://doi.org/10.1007/978-94-017-9361-2_3openalex-snapshot
In Vivo Imaging in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-981-97-4864-8_8openalex-snapshot
O-GlcNAcylation in Neuronal Development, Neurodegeneration, and Neurological Disorders
inferred← citeshttps://doi.org/10.1007/bf02984652openalex-snapshot
Necessity of a uniform start for scanning after FDG injection in brain PET study
inferred← citeshttps://doi.org/10.1007/s00018-017-2542-9openalex-snapshot
The emerging link between O-GlcNAcylation and neurological disorders
inferred← citeshttps://doi.org/10.1007/s00109-019-01856-zopenalex-snapshot
c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments
inferred← citeshttps://doi.org/10.1007/s00115-010-3213-3openalex-snapshot
Diagnose ohne Therapie
inferred← citeshttps://doi.org/10.1007/s00115-018-0533-1openalex-snapshot
Bedeutung molekularer Bildgebung (PET) in der Diagnostik von Demenzerkrankungen
inferred← citeshttps://doi.org/10.1007/s00117-016-0124-8openalex-snapshot
Molekulare Bildgebung bei neurologischen Erkrankungen
inferred← citeshttps://doi.org/10.1007/s00234-011-0900-0openalex-snapshot
Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study
inferred← citeshttps://doi.org/10.1007/s00259-005-1762-7openalex-snapshot
Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease
inferred← citeshttps://doi.org/10.1007/s00259-005-1936-3openalex-snapshot
PET is better than perfusion SPECT for early diagnosis of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00259-007-0406-5openalex-snapshot
Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00259-007-0454-xopenalex-snapshot
Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00259-007-0626-8openalex-snapshot
Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations
inferred← citeshttps://doi.org/10.1007/s00259-008-0773-6openalex-snapshot
Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study
inferred← citeshttps://doi.org/10.1007/s00259-008-0833-yopenalex-snapshot
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00259-008-0869-zopenalex-snapshot
Principal component analysis of FDG PET in amnestic MCI
inferred← citeshttps://doi.org/10.1007/s00259-008-1039-zopenalex-snapshot
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00259-009-1301-zopenalex-snapshot
Radiopharmaceuticals for positron emission tomography investigations of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00259-013-2458-zopenalex-snapshot
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia
inferred← citeshttps://doi.org/10.1007/s00259-013-2478-8openalex-snapshot
[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
inferred← citeshttps://doi.org/10.1007/s00259-014-2704-zopenalex-snapshot
The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00259-017-3634-3openalex-snapshot
Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline
inferred← citeshttps://doi.org/10.1007/s00259-017-3790-5openalex-snapshot
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage
inferred← citeshttps://doi.org/10.1007/s00259-017-3832-zopenalex-snapshot
Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET
inferred← citeshttps://doi.org/10.1007/s00259-018-4039-7openalex-snapshot
Clinical utility of FDG-PET for the clinical diagnosis in MCI
inferred← citeshttps://doi.org/10.1007/s00259-018-4248-0openalex-snapshot
Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer’s disease and mild cognitive impairment
inferred← citeshttps://doi.org/10.1007/s00259-019-04559-2openalex-snapshot
Brain metabolic signatures across the Alzheimer’s disease spectrum
inferred← citeshttps://doi.org/10.1007/s00259-019-04676-yopenalex-snapshot
Slice-selective learning for Alzheimer’s disease classification using a generative adversarial network: a feasibility study of external validation
inferred← citeshttps://doi.org/10.1007/s00259-020-04694-1openalex-snapshot
Direct prospective comparison of 18F-FDG PET and arterial spin labelling MR using simultaneous PET/MR in patients referred for diagnosis of dementia
inferred← citeshttps://doi.org/10.1007/s00259-020-04714-0openalex-snapshot
Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters
inferred← citeshttps://doi.org/10.1007/s00259-022-05879-6openalex-snapshot
Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment
inferred← citeshttps://doi.org/10.1007/s00259-022-05915-5openalex-snapshot
Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer’s disease: additional results from the AMBAR study
inferred← citeshttps://doi.org/10.1007/s00401-009-0522-3openalex-snapshot
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00401-015-1386-3openalex-snapshot
Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
inferred← citeshttps://doi.org/10.1007/s00406-011-0226-2openalex-snapshot
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI
inferred← citeshttps://doi.org/10.1007/s00415-007-0631-7openalex-snapshot
Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment
inferred← citeshttps://doi.org/10.1007/s00415-008-0897-4openalex-snapshot
Brain SPECT in subtypes of mild cognitive impairment
inferred← citeshttps://doi.org/10.1007/s00415-009-5396-8openalex-snapshot
Amyloid PET in mild cognitive impairment and Alzheimer’s disease with BF-227: comparison to FDG–PET
inferred← citeshttps://doi.org/10.1007/s00415-012-6428-3openalex-snapshot
Positron emission tomography imaging in neurological disorders
inferred← citeshttps://doi.org/10.1007/s00586-008-0682-1openalex-snapshot
Cerebral glucose metabolic abnormality in patients with congenital scoliosis
inferred← citeshttps://doi.org/10.1007/s10072-011-0633-1openalex-snapshot
The concept of FDG-PET endophenotype in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s10072-013-1407-8openalex-snapshot
Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8)
inferred← citeshttps://doi.org/10.1007/s10787-012-0130-zopenalex-snapshot
The role of inflammatory processes in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s11064-007-9296-yopenalex-snapshot
Indices of Metabolic Dysfunction and Oxidative Stress
inferred← citeshttps://doi.org/10.1007/s11064-012-0854-6openalex-snapshot
Quintessential Risk Factors: Their Role in Promoting Cognitive Dysfunction and Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/s11065-015-9297-6openalex-snapshot
FDG-PET Contributions to the Pathophysiology of Memory Impairment
inferred← citeshttps://doi.org/10.1007/s11095-014-1522-0openalex-snapshot
Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights
inferred← citeshttps://doi.org/10.1007/s11307-005-0953-8openalex-snapshot
Toward the Validation of Functional Neuroimaging as a Potential Biomarker for Alzheimer?s Disease: Implications for Drug Development
inferred← citeshttps://doi.org/10.1007/s11307-009-0247-7openalex-snapshot
Surface Feature-Guided Mapping of Cerebral Metabolic Changes in Cognitively Normal and Mildly Impaired Elderly
inferred← citeshttps://doi.org/10.1007/s11427-009-0089-1openalex-snapshot
The role of the DLPFC in inductive reasoning of MCI patients and normal agings: An fMRI study
inferred← citeshttps://doi.org/10.1007/s11571-010-9138-5openalex-snapshot
Sensory evoked and event related oscillations in Alzheimer’s disease: a short review
inferred← citeshttps://doi.org/10.1007/s11604-006-2408-9openalex-snapshot
Functional neuroimaging in Alzheimer's disease
inferred← citeshttps://doi.org/10.1007/s11682-011-9142-3openalex-snapshot
3D texture analysis on MRI images of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s11682-015-9356-xopenalex-snapshot
Multimodal manifold-regularized transfer learning for MCI conversion prediction
inferred← citeshttps://doi.org/10.1007/s11940-017-0484-zopenalex-snapshot
Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia
inferred← citeshttps://doi.org/10.1007/s12021-013-9180-7openalex-snapshot
Semi-Supervised Multimodal Relevance Vector Regression Improves Cognitive Performance Estimation from Imaging and Biological Biomarkers
inferred← citeshttps://doi.org/10.1007/s12035-008-8019-yopenalex-snapshot
The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias
inferred← citeshttps://doi.org/10.1007/s12035-012-8375-5openalex-snapshot
A Non-transgenic Mouse Model (icv-STZ Mouse) of Alzheimer’s Disease: Similarities to and Differences from the Transgenic Model (3xTg-AD Mouse)
inferred← citeshttps://doi.org/10.1007/s12035-015-9638-8openalex-snapshot
Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts
inferred← citeshttps://doi.org/10.1007/s12035-020-02023-zopenalex-snapshot
The Role of Neurovascular System in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/s12035-021-02297-xopenalex-snapshot
Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism
inferred← citeshttps://doi.org/10.1007/s12046-023-02219-8openalex-snapshot
Early diagnosis of Alzhiemer’s disease using wavelet-pooling based deep convolutional neural network
inferred← citeshttps://doi.org/10.1007/s12149-009-0316-7openalex-snapshot
Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys
inferred← citeshttps://doi.org/10.1007/s12149-013-0704-xopenalex-snapshot
Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study
inferred← citeshttps://doi.org/10.1007/s12149-026-02257-2openalex-snapshot
A real-world decision tree model based on ¹⁸F-FDG PET/CT Z scores and Mini-Mental State Examination for differentiating mild cognitive impairment from clinically diagnosed Alzheimer disease
inferred← citeshttps://doi.org/10.1007/s12151-007-0025-2openalex-snapshot
Mild Cognitive Impairment – MCI
inferred← citeshttps://doi.org/10.1007/s12264-013-1408-xopenalex-snapshot
Deregulation of brain insulin signaling in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s12640-016-9643-3openalex-snapshot
Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/s12640-017-9809-7openalex-snapshot
Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer’s Rat Model
inferred← citeshttps://doi.org/10.1007/s40336-013-0026-yopenalex-snapshot
Glucose metabolism in normal aging and Alzheimer’s disease: methodological and physiological considerations for PET studies
inferred← citeshttps://doi.org/10.1007/s40336-013-0042-yopenalex-snapshot
Multiagent imaging of the brain
inferred← citeshttps://doi.org/10.1016/b978-0-12-407824-6.00040-9openalex-snapshot
Ketosis in Mild Cognitive Impairment and Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-800105-9.00017-2openalex-snapshot
Neuroimaging Advances in Alzheimer's Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-816386-3.00085-5openalex-snapshot
PET and SPECT Imaging of Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-444-53086-8.00002-3openalex-snapshot
Application of 18F‐PET Imaging for the Study of Alzheimer's Disease
inferred← citeshttps://doi.org/10.1016/b978-0-444-64196-0.00008-xopenalex-snapshot
Cingulate-centered large-scale networks: Normal functions, aging, and neurodegenerative disease
inferred← citeshttps://doi.org/10.1016/b978-044452809-4/50153-8openalex-snapshot
The Key Role of Oxidative Stress in Alzheimer's Disease
inferred← citeshttps://doi.org/10.1016/b978-343723390-6.50013-9openalex-snapshot
Möglichkeiten und Bedeutung nuklearmedizinischer Diagnostik: PET und SPECT
inferred← citeshttps://doi.org/10.1016/j.archger.2020.104085openalex-snapshot
Spect-neuropsychology correlations in very mild Alzheimer's disease and amnesic mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.archger.2021.104359openalex-snapshot
“2-step MCI-AD”: a simple scoring system to predict rapid conversion from mild cognitive impairment to Alzheimer dementia
inferred← citeshttps://doi.org/10.1016/j.arr.2016.01.004openalex-snapshot
Neuroimaging biomarkers in Alzheimer’s disease and other dementias
inferred← citeshttps://doi.org/10.1016/j.arr.2016.01.005openalex-snapshot
Amyloid imaging: Past, present and future perspectives
inferred← citeshttps://doi.org/10.1016/j.artmed.2012.09.005openalex-snapshot
Bilateral symmetry aspects in computer-aided Alzheimer's disease diagnosis by single-photon emission-computed tomography imaging
inferred← citeshttps://doi.org/10.1016/j.banm.2026.03.020openalex-snapshot
Actualités de la maladie d’Alzheimer
inferred← citeshttps://doi.org/10.1016/j.bbadis.2011.11.006openalex-snapshot
The use of PIB-PET as a dual pathological and functional biomarker in AD
inferred← citeshttps://doi.org/10.1016/j.bbadis.2018.10.037openalex-snapshot
Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies
inferred← citeshttps://doi.org/10.1016/j.bbr.2018.02.017openalex-snapshot
Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging
inferred← citeshttps://doi.org/10.1016/j.biopsych.2004.05.014openalex-snapshot
Association of elevated phospho-tau levels with alzheimer-typical 18F-Fluoro-2-Deoxy-D-Glucose positron emission tomography findings in patients with mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.biopsych.2011.04.023openalex-snapshot
Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay
inferred← citeshttps://doi.org/10.1016/j.biopsych.2011.09.027openalex-snapshot
Asymmetric Loss of Parietal Activity Causes Spatial Bias in Prodromal and Mild Alzheimer's Disease
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2008.01.010openalex-snapshot
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2016.08.002openalex-snapshot
O-GlcNAcylation and neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.clinph.2008.01.105openalex-snapshot
Increased biomagnetic activity in the ventral pathway in mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.cnr.2007.05.003openalex-snapshot
Identifying functional imaging markers of mild cognitive impairment in early Alzheimer’s and Parkinson’s disease using multivariate analysis
inferred← citeshttps://doi.org/10.1016/j.compmedimag.2022.102140openalex-snapshot
Template-based graph registration network for boosting the diagnosis of brain connectivity disorders
inferred← citeshttps://doi.org/10.1016/j.cpet.2009.12.003openalex-snapshot
Evaluation of Early Dementia (Mild Cognitive Impairment)
inferred← citeshttps://doi.org/10.1016/j.cpet.2009.12.008openalex-snapshot
Amyloid PET Ligands for Dementia
inferred← citeshttps://doi.org/10.1016/j.cpet.2013.10.007openalex-snapshot
Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging
inferred← citeshttps://doi.org/10.1016/j.cpet.2014.07.005openalex-snapshot
Fluorodeoxyglucose PET in Neurology and Psychiatry
inferred← citeshttps://doi.org/10.1016/j.dadm.2018.07.010openalex-snapshot
Do 2‐year changes in superior frontal gyrus and global brain atrophy affect cognition?
inferred← citeshttps://doi.org/10.1016/j.dcan.2025.04.001openalex-snapshot
Role of deep learning in cognitive healthcare: Wearable signal analysis, algorithms, benefits, and challenges
inferred← citeshttps://doi.org/10.1016/j.exger.2006.05.016openalex-snapshot
Early detection of Alzheimer’s disease using neuroimaging
inferred← citeshttps://doi.org/10.1016/j.ins.2010.10.027openalex-snapshot
18F-FDG PET imaging analysis for computer aided Alzheimer’s diagnosis
inferred← citeshttps://doi.org/10.1016/j.jagp.2020.06.006openalex-snapshot
Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging
inferred← citeshttps://doi.org/10.1016/j.jalz.2005.06.003openalex-snapshot
Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI)
inferred← citeshttps://doi.org/10.1016/j.jalz.2008.04.005openalex-snapshot
Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.jalz.2009.01.019openalex-snapshot
Early risk assessment for Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.jalz.2009.04.1172openalex-snapshot
P3‐096: 99mTc HMPAO SPECT prediction of conversion from mild cognitive impairment to Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.jalz.2009.05.013openalex-snapshot
IC‐O1‐03: From mild cognitive impairment to Alzheimer's disease: comparisons of metabolic and structural brain alteration evolutions
inferred← citeshttps://doi.org/10.1016/j.jalz.2009.09.005openalex-snapshot
Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow‐up at 3 years
inferred← citeshttps://doi.org/10.1016/j.jalz.2010.03.002openalex-snapshot
The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
inferred← citeshttps://doi.org/10.1016/j.jalz.2010.03.008openalex-snapshot
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
inferred← citeshttps://doi.org/10.1016/j.jalz.2010.05.515openalex-snapshot
PL‐05‐03: Metabolic and molecular imaging markers throughout the course of Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.jalz.2012.07.003openalex-snapshot
Impact of molecular imaging on the diagnostic process in a memory clinic
inferred← citeshttps://doi.org/10.1016/j.jalz.2013.02.007openalex-snapshot
The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults
inferred← citeshttps://doi.org/10.1016/j.jalz.2013.12.012openalex-snapshot
Evaluation of neuroprotective effect of glucagon‐like peptide 1 analogs using neuroimaging
inferred← citeshttps://doi.org/10.1016/j.jns.2004.02.011openalex-snapshot
Cerebral blood flow patterns in Binswanger's disease: a SPECT study using three-dimensional stereotactic surface projections
inferred← citeshttps://doi.org/10.1016/j.jocn.2004.03.011openalex-snapshot
Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.lpmfor.2022.01.013openalex-snapshot
Biomarqueurs de la maladie d’Alzheimer : des avancées très rapides
inferred← citeshttps://doi.org/10.1016/j.mehy.2013.09.008openalex-snapshot
Alzheimer’s disease: A gas model. The NADPH oxidase–Nitric Oxide system as an antibubble biomachinery
inferred← citeshttps://doi.org/10.1016/j.mibio.2004.05.002openalex-snapshot
Positron emission tomography in clinical neurology
inferred← citeshttps://doi.org/10.1016/j.mito.2006.10.004openalex-snapshot
Impaired platelet mitochondrial activity in Alzheimer’s disease and mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.molmet.2024.101941openalex-snapshot
LRP1 in GABAergic neurons is a key link between obesity and memory function
inferred← citeshttps://doi.org/10.1016/j.ncl.2017.01.010openalex-snapshot
The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2011.06.009openalex-snapshot
Parietal cortex matters in Alzheimer's disease: An overview of structural, functional and metabolic findings
inferred← citeshttps://doi.org/10.1016/j.neucom.2010.06.025openalex-snapshot
Principal component analysis-based techniques and supervised classification schemes for the early detection of Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neulet.2011.06.036openalex-snapshot
Changes in cerebral glucose metabolism in patients with mild-to-moderate Alzheimer's disease: A pilot study with the Chinese herbal medicine fuzhisan
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2005.05.002openalex-snapshot
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2005.09.017openalex-snapshot
Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2005.11.002openalex-snapshot
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2006.06.018openalex-snapshot
Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2006.12.008openalex-snapshot
Hippocampal hypometabolism predicts cognitive decline from normal aging
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2007.03.029openalex-snapshot
PET imaging of amyloid deposition in patients with mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2008.05.001openalex-snapshot
Functional compensation in incipient Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2009.01.013openalex-snapshot
Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2009.07.002openalex-snapshot
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2010.04.013openalex-snapshot
Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2011.03.003openalex-snapshot
Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2012.10.011openalex-snapshot
APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2014.12.033openalex-snapshot
Neurotoxicity and synaptic plasticity impairment of N-acetylglucosamine polymers: implications for Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2014.12.036openalex-snapshot
Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent manner
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2022.02.012openalex-snapshot
Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.neuroimage.2005.06.066openalex-snapshot
The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT
inferred← citeshttps://doi.org/10.1016/j.neuroimage.2008.12.072openalex-snapshot
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
showing the first 200 of 579 · page through all 579
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.